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SUMMARY
This study compared the clinical and radiographic responses 
after 3 months to a sterile compression technique with zinc 
oxide-eugenol or 15.5°/o ferric sulphate in 145 pulpotomised 
primary teeth in 30 children. In both groups of teeth the 
success rate was 100%. These short-term results suggest that 
either technique may be used.
Introduction
Pulpotomy in paediatric dentistry has a long clinical 
history. Because of the ability of injured pulpal tissue to 
heal, dentists have tried'various techniques and materi­
als to preserve its vitality whenever possible. In pulpo­
tomy, only the coronal part of the pulp tissue is 
removed to leave the residual vital, radicular pulp tissue 
intact, which is either preserved or stimulated to repair 
and regenerate, depending on the technique and mate­
rial used.
Pulp therapy in primary teeth differs from similar treat­
ment in permanent teeth because the root canals of 
primary teeth are more complex than those in perma­
nent teeth, having lateral canals that often link with 
each other, making removal of tissue in them very diffi­
cult. Also, the developing permanent teeth are below 
their predecessors. It is important to use a pulpotomy 
material that is biocompatible and which does not 
interfere with the exfoliation of the primary teeth or 
with the eruption of the underlying permanent teeth.
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OPSO M M ING
In hierdie studie word die kliniese en radiologiese reaksie na 
3 maande op ’n steriele kompressietegniek met 'n sinkoksied- 
eugenol of 15.5% ferrisulfaat in 145 gepulpotimiseerde 
primere tande van 30 kinders vergelyk. In albei groepe is 
100% sukses bebaal. Hierdie korttermyn resultate dui daarop 
dat beide tegnieke gebruik mag word.
Formocresol was the first pulpotomy material to pro­
duce good clinical results (Buckley, 1904). It is a bacte­
ricidal agent that also fixes, or mummifies the residual 
radicular pulp tissue (Nunn, Smeaton and Gilroy, 1996). 
While it is a reliable pulpotomy material (Avram and 
Pulver, 1989; Morawa et al., 1975), it has cytotoxic 
effects (Kettey and Goodman, 1991; Ranly and Horn, 
1987; Ranly 1985), and mutagenic and carcinogenic 
risks (Judd and Kenny, 1987; Goldmacher and Thilley, 
1983; Lewis and Chestner, 1981) which is important 
since it is absorbed and distributed systemically from 
the pulpotomy sites (Rusmah and Rahim, 1992; Pashley 
et a l ,  1980; Myers et al., 1978). Because of its poten­
tially harmful effects, formocresol is no longer regarded 
as an ideal material to use in pulpotomies (Nunn, 
Smeaton and Gilroy, 1996; Kettey and Goodman, 1991; 
Judd and Kenny, 1987).
Glutaraldehyde has been shown to be a better pulp fix­
ative than formocresol (Ranly and Lazzari, 1983; Davis, 
Myers and Switkes, 1982). It is more self-limiting in 
penetration because of cross-linking properties and its 
larger molecular size (Rusmah and Rahim, 1992; Ranly 
and Lazzari, 1983); it is also less antigenic and cytotox­
ic than formocresol (Ranly, Horn and Hubbard, 1989; 
Wemes et al., 1982), but it is still absorbed and distrib­
uted systematically (Ranly et al., 1989), although most 
of the absorbed dose is said to be eliminated within 
3 days (Myers et al., 1986). Generally, the success rate 
is not as high as reported for formocresol pulpotomy 
(Tsai, Su and Tseng, 1993; Fuks et al., 1990).
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Calcium hydroxide, with its high pH and its ability to 
stimulate tissue repair and to induce the formation of 
reparative dentine formation, has also been used as a 
pulpotomy material (Cvek et al., 1987; Guo and 
Messer, 1976; Heithersay, 1975). The stimulus evoked 
by calcium hydroxide is delicately balanced between 
one of repair and one of resorption (Cvek et a l ,  1987), 
thus many pulpotomised teeth treated with calcium 
hydroxide end up with internal resorption. Although it 
is considered a safe material when compared with 
formocresol, owing to its high failure rate, there are no 
strong arguments for its use in primary tooth pulpo- 
tomies (Gruythuysen and Smits, 1995; Schroder, 1978).
A non-aldehyde chemical, ferric sulphate, a powerful 
haemostatic agent, has received attention recently as a 
pulpotomy agent (Fuks et al., 1997). Landau and 
Johnsen (1988) first tested this material as pulpotomy 
agent in monkeys, and observed a histological response 
superior to that in pulps treated with calcium hydroxide 
after 60 days. This was followed by a clinical study (Fei, 
Udin and Johnson, 1991) which showed a successful 
pulpotomy with ferric sulphate in 28 out of 29 teeth 
after 12 months. In another clinical study, Buskin 
(1995) showed a 100% clinical success rate after 3 
months in 38 teeth treated with 15.5% ferric sulphate. 
Although both clinical studies have shown high success 
rates, the samples sizes were relatively small and the 
observation periods were short.
Recently, several other pulpotomy methods have been 
proposed, e.g. feracrylum (Prabhu and Munshi, 1997), 
electrofulguration (Fishman et al., 1996), argon laser 
(Wilkerson, Hill and Arcoria, 1996) and bone morpho­
genetic protein (Ranly, 1994), but these methods are 
not yet accepted and some are expensive.
Zinc oxide-eugenol is the most widely used base mater­
ial in pulpotomies, but earlier studies have revealed 
some negative effects when it is placed directly onto 
pulp tissue (Magnusson and Schroder, 1981). More 
recently, Fuks et al. (1991) demonstrated equally 
favourably histological tissue responses to zinc oxide- 
eugenol and glutaraldehyde pulpotomies in baboon 
teeth. Other supporters of the technique are Croll and 
Killian (1992), who described a zinc oxide-eugenol 
pulpotomy technique which they claimed to be ‘most 
valuable and reliable in clinical use over the past 20 
years’, but regrettably provided no statistics to support 
this. These reports of good tissue response to zinc 
oxide-eugenol question the need for a fixative in 
pulpotomies, even one with few deleterious effects such 
as glutaraldehyde.
If a non-fixative is to be used, ferric sulphate pulpoto­
my is promising although not yet generally accepted
since there are only two reported studies in children 
(Buskin, 1995; Fei et al., 1991). Zinc oxide-eugenol is a 
well-accepted material in clinical dentistry and is known 
to be safe when used in humans. Zinc oxide-eugenol 
pulpotomy, however, has only been reported in animal 
studies as a control material (Fishman et al., 1996;
Fuks et al., 1991; Lloyd, Seale and Wilson, 1988). There 
are no publication on the clinical outcome of the tech­
nique in children. Although there have been varying 
interpretations of the histological responses of the pul- 
pal tissues to zinc oxide-eugenol, animal research (Fuks 
et a l ,  1991) has shown that with careful case selection 
and proper manipulation of the material, it may per­
form just as well as glutaraldehyde.
The aim of this study was to compare the clinical 
success of ferric sulphate and zinc oxide-eugenol 
pulpotomies.
Materials and methods
After ethical approval by the university’s Committee for 
Research on Human Subjects, informed consent was 
obtained from children and their parents to participate 
in the study. The children, aged between two and nine 
years, required at least two pulpotomies of primary 
teeth on each side of the mouth to allow a paired 
design for intra-person comparison.
Teeth were included in the study according to clinical 
and radiographic criteria. Clinically there had to be no 
fistulae, no excessive mobility, no tenderness to percus­
sion and sufficient remaining tooth to allow restoration. 
Radiographic criteria were a carious exposure of the 
pulp, no internal or external resorption, no calcific pul- 
pal degeneration, and no inter-radicular or periapical 
radiolucencies.
All the children in the study required general anaesthe­
sia because of the extensive treatment that they need­
ed. In both materials groups, the current standard 
pulpotomy technique at the University of the 
Witwatersrand Dental School was used as follows: After 
placement of rubber dam, caries was removed using a 
sterile round carbide bur (#6) before deroofing of the 
pulp chamber under continuous water irrigation. The 
coronal pulpal tissues were removed with a slow- 
running sterile round bar, followed immediately by a 
copious sterile physiological saline rinse using a 20 ml 
syringe and 15 gauge needle.
At this stage, haemostasis was achieved by two meth­
ods. In one group of teeth 15.5% ferric sulphate 
(Astringedent, Ultradent Products Inc., South Jordan, 
Utah, USA) was gently applied to the pulpal stumps 
with the applicator (Dento-infusor) supplied by the
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manufacturer. If  bleeding persisted, there was a second 
application, in the second (zinc oxide-eugenol) group 
light pressure was applied with sterile cotton pellets on 
the cut pulp.
Once haemostasis had been achieved, a thick mix of 
pure zinc oxide-eugenol paste (3M Dental Products, St 
Paul, Minnesota, OSA) was placed into the pulp cham­
ber in both groups and allowed to set. For the final 
restoration, either amalgam restorations (Oralloy 
Magicaps, Coltene, Maiwah, New Jersey, USA) or stain­
less steel crowns (Ion Ni-Chro crowns, 3M Dental 
Products, St Paul, Minnesota, USA) were placed.
The number of teeth requiring pulpotomies was not 
always equal on both sides of the mouth, so a perfect 
paired experimental design was not possible for all 
patients. Since ferric sulphate is the current standard 
procedure for pulpotomies at the university’s dental 
school, it was decided, on ethical grounds, that the side 
of the mouth with more teeth needing pulpotomies 
would be assigned to the 15.5% ferric sulphate group, 
and the opposite side would receive the zinc oxide- 
eugenol treatment. All parents were requested to con­
tact the operator if pain developed during the post­
operative period.
Bite wing radiographs (DF54, 2 cm X 3 cm intraoral 
film) of the study teeth, which included the primary 
tooth apices, were taken pre-operatively, postoperatively 
and at the follow-up visit using a 70kV X-ray machine, 
and with patients wearing protective lead aprons.
The study design required postoperative evaluation to 
be done 3 months after the pulpotomy. The operator 
who had done the pulpotomy did the clinical assess­
ment. Teeth were judged clinically successful if there 
was no pain or tenderness to percussion, swelling, fis- 
tulae, or furcation involvement. The pain or tenderness 
to percussion was measured as either present or absent, 
after gently tapping the tooth with the back of an 
intraoral mirror. Furcal involvement was assessed with a 
periodontal probe. Radiographic evaluation was made 
by three other dentists, blind to the treatment used, 
who discussed each radiograph to reach a consensus. 
Radiographic success required a normal periodontal lig­
ament, absence of internal or external root resorption, 
and no intraradicular or periapical radiolucency.
Statistical analysis was planned as follows: The 
University of the Witwatersrand’s Sun SPARCcentre 
2000 computer running in UNIX would be used with 
SAS (1990) to apply a linear-logistic analysis. Pain, fur­
cal and periapical radiolucencies would be the depen­
dent variables, and child, jaw side and treatment mate­
rials would be the independent variables. The critical 
level of statistical significance was set at P < 0.05.
Results
In order to obtain 30 children at the 3-month follow­
up, 41 children had to be included in the study. Eleven 
did not return for a follow-up visit. No parents contact­
ed the operator to report pain.
A total of 145 pulpotomies were performed in the 30 
children (18 girls, 12 boys). The childrens’ ages ranged 
from 2.2 years to 9.7 years, with a mean age of 5.9 
years (SD 2.0, Table 1). There was a mean of 4.8 pulpo­
tomies per child. The number of pulpotomies performed 
at each age is shown in Table 11.
Table I. Numbers of children by age and gender, 
and percentage of sample
Age Female Male Total
(years) N o/o N o/o N o/o
2 2 6.7 0 0 2 6.7
3 2 6.7 2 6.7 4 13.3
4 1 3.3 4 13.3 5 16.7
5 3 10.0 1 3.3 4 13.3
6 3 10.0 1 3.3 4 13.3
7 5 16.7 3 10.0 8 26.7
8 0 0 0 0 0 0
9 2 6.7 1 3.3 3 10.0
Total 18 60 12 40 30 100
Table II. Number of pulpotomies by age and 
gender^ and percentage of all pulpotomiesl
Age Female Male Total
(years) N  o/o N  % N  %
2 9 6.2 0 0 9 6.2
3 15 10.3 8 5.5 23 15.9
4 4 2.8 16 11.0 20 13.8
5 10 6.9 4 2.8 14 9.7
6 19 13.1 6 4.1 25 17.2
7 22 15.2 19 13.1 41 28.3
8 0 0 0 0 0 0
9 7 4.8 6 4.1 13 8.9
Total 86 40.7 59 40.7 145 100
The distribution of teeth treated is shown in Table 111. Of 
the 145 pulpotomised teeth, 74 were on the right side 
and 71 on the left; 76 teeth were in the ferric sulphate 
group and 69 teeth were in the zinc oxide-eugenol group. 
Eighteen teeth that required pulpotomies were anterior 
teeth, 127 were posterior teeth. The tooth with the high­
est frequency of pulpotomies was tooth 74 (20 pulpo­
tomies), followed in descending order by tooth 84 (18),
54 (17), 64 and 75 (16 each), 85 (15), 55 (12), and 65 
(11). A total of 76 mandibular molars had pulpotomies 
performed compared with 56 maxillary molars.
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Table III. Number of pulpotomies by tooth and 
material, and percentage of all pulpotomies
Tooth Ferric sulphate Zinc oxide-eugenol Total
N % N o/o N %
51 1 0.7 5 3.5 6 4.2
52 1 0.7 3 2.1 4 2.8
53 •1 0.7 0 0 1 0.7
54 10 6.7 7 4.8 17 11.7
55 6 4.1 6 4.1 12 8.2
61 3 2.1 1 0.7 4 2.8
62 3 2.1 1 0.7 4 2.8
63 0 0 0 0 0 0
64 6 4.1 10 6.9 16 11.0
65 7 4.8 4 2.8 11 7.6
71 0 0 0 0 0 0
72 0 0 0 0 0 0
73 0 0 0 0 0 0
74 11 7.6 9 6.2 20 13.8
75 8 5.5 8 5.5 16 11.0
81 0 0 0 0 0 0
82 0 0 0 0 0 0
83 1 0.7 0 0 1 0.7
84 10 6.9 8 5.5 18 12.4
85 8 5.5 7 4.8 15 10.3
Total 76 52.4 69 47.6 145 100
All the teeth in the study, whether in the ferric sulphate 
or zinc oxide-eugenol groups, were judged to be clini­
cally and radiographically successful. Due to the clear 
outcome no statistical analysis was required. A typical 
example of 3-month postoperative radiograph of a 
zinc-oxide pulpotomy after a carious exposure of the 
pulp is shown in Fig. 1.
Fig. I.A  bite-wing radiograph at the 3-month recall 
visit showing tooth 74 with a zinc oxide-eugenol 
pulpotomy and amalgam restoration.
Discussion
The main objective of the pulpotomy in primary teeth 
is to retain the tooth in the dental arch until normal 
resorption and exfoliation occurs. To realise this any 
pulpotomy medicament must produce clinical and 
radiographic success as was measured in the current 
study. All the pulpotomies in this study were successful 
at 3 months, with no differences between the ferric 
sulphate and the zinc oxide-eugenol methods.
Although the time to achieve haemostasis after pulpal 
amputation was not recorded, haemostasis appeared to 
be achieved sooner with ferric sulphate (approximately 
5 minutes), than when the residual pulp stumps were 
gently compressed with a sterile cotton pellet (about
2- 3 minutes longer than ferric sulphate).
When pulpotomy success should be assessed in primary 
teeth has not been defined in the dental literature. 
Assessment time periods in published pulpotomy studies 
have varied considerably, from 2 to 12 months or even 
longer (Cotes et al., 1997; Fuks ef a i, 1997; Fishman 
er al., 1996; Buskin, 1995; Fei e t a /., 1991;Laundau 
and Johnsen, 1988; Magnusson and Schroder, 1981). 
Ideally, the longer the follow-up period the better the 
chance for pathology to manifest. Flowever, choice of 
timing is influenced by the likelihood of tooth exfolia­
tion, which depends on the age of presentation of the 
child and the tooth concerned, as well as the likelihood 
of patient return for assessment of the treatment. The
3- month follow-up period chosen for the present study 
was based on clinical experience, because if a pulpoto­
my is going to fail it should become evident within
3 months.
This study has shown excellent clinical and radiographic 
results for both 15.5% ferric sulphate and zinc oxide- 
eugenol as pulpotomy medicaments. The high succcess 
rate of both materials in this study agrees with the 
results of previous studies by Fuks et al. (1997),
Fishman et al., (1996), Buskin (1995) and Fei ef al., 
(1991). The successful clinical and radiographic results 
also correlate with the histological findings of Fuks ef 
a i ,  (1991) and Landau and Johnsen (1988) which 
showed little inflammation and no abscess formation in 
the pulpal tissues treated with both materials.
Both materials used in the present study are readily 
available to any general dental practitioner. Ferric sul­
phate is the more expensive of the two, has a limited 
shelf life and is recommended to be used with a special 
applicator. It is commonly used by dentists for 
haemostasis before taking impressions. Zinc oxide- 
eugenol is one of the most widely used dental materi­
als, is inexpensive and has a very long shelf life.
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The current investigation, however, was a short-term 
study with a 3-month follow-up period. According to 
the guidelines used in treating paediatric patients at the 
University of the Witwatersrand Dental School and 
based on other published work (Mathewson ef a l ,
1982; Kennedy and Kapala, 1980), one of the criteria 
for considering pulpotomy is an expected lifespan of 
the treated tooth of 18 months. Therefore, a longer 
observation period of up to 18 months would be ideal 
to evaluate any long-term detrimental effects.
Conclusion
Both 15.5°/o ferric sulphate and zinc oxide-eugenol are 
good alternative pulpotomy medicaments to formo- 
cresol or glutaraldehyde. Final choice of pulpotomy 
technique is up to the individual clinician. In the con­
text of a Third World situation or in rural areas where 
material availability is a problem, the zinc oxide- 
eugenol pulpotomy technique is recommended because 
it involves one material less, reduces the pulpotomy 
cost but achieves the same result as 15.5% ferric 
sulphate.
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